Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M<sup>pro</sup>
In the latest few decades, molecular docking has imposed itself as one of the most used approaches for computational drug discovery. Several docking benchmarks have been published, comparing the performance of different algorithms in respect to a molecular target of interest, usually evaluating thei...
Saved in:
Main Authors: | Davide Bassani (Author), Matteo Pavan (Author), Giovanni Bolcato (Author), Mattia Sturlese (Author), Stefano Moro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
by: Matteo Pavan, et al.
Published: (2021) -
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022) -
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists?
by: Davide Bassani, et al.
Published: (2022) -
A Tale of Two Proteases: M<sup>Pro</sup> and TMPRSS2 as Targets for COVID-19 Therapies
by: Barbara Farkaš, et al.
Published: (2023) -
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
by: Matteo Pavan, et al.
Published: (2022)